Expertise in
20
conditions

Dr. Jaykumar Thumar

Hematology | Oncology
Hartford Healthcare Cancer Institute
85 Jefferson St, Ste 210, 
Hartford, CT 
Offers Telehealth
Expertise in
20
conditions
Hartford Healthcare Cancer Institute
85 Jefferson St, Ste 210, 
Hartford, CT 

Overview

Jaykumar Thumar is a Hematologist and an Oncologist practicing medicine in Hartford, Connecticut.

Dr. Thumar is highly rated in 20 conditions, according to our data. His clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Essential Thrombocythemia, Classical Hodgkin Lymphoma, and Hodgkin Lymphoma.

He is actively involved in clinical research, co-authoring 11 peer reviewed articles and participating in 2 clinical trials.

Specialties

Hematology
Oncology

Licenses

Internal Medicine in CT

Hospital Affiliations

Hartford Hospital
The Hospital Of Central Connecticut
Windham Community Memorial Hospital
Midstate Medical Center
William W Backus Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health New England
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MetroPlus Health
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Oscar
  • EPO
  • HMO
  • PPO
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Hartford Healthcare Cancer Institute
85 Jefferson St, Ste 210, Hartford, CT 06106
Other Locations
Hartford Healthcare Medical Group
85 Seymour St Ste 125, Hartford, CT 06106
Hartford Healthcare Medical Group
85 Retreat Ave, Hartford, CT 06106

Additional Areas of Focus

Dr. Thumar has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Metastatic Uveal Melanoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Enrollment Status: Active_not_recruiting
Publish Date: August 04, 2026
Intervention Type: Other, Procedure, Drug
Study Drugs: Atezolizumab, 5-Fluorouracil, Leucovorin, Oxaliplatin
Study Phase: Phase 3
A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers
A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers
Enrollment Status: Completed
Publish Date: January 12, 2026
Intervention Type: Drug
Study Drugs: Cisplatin, Gemcitabine, Nab-Paclitaxel
Study Phase: Phase 3
View 1 Less Clinical Trial

11 Total Publications

YIA26-003: Characterizing the Peripheral T-Cell Repertoire in Patients With Unresectable Melanoma Treated With the IDO- and PD-L1 Targeted Peptide Vaccine IO102-IO103 and Nivolumab-Relatlimab Fixed-Dose Combination.
YIA26-003: Characterizing the Peripheral T-Cell Repertoire in Patients With Unresectable Melanoma Treated With the IDO- and PD-L1 Targeted Peptide Vaccine IO102-IO103 and Nivolumab-Relatlimab Fixed-Dose Combination.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 29, 2026
Similar Doctors
Expertise in
11
conditions
Dr. Farzana D. Pashankar
Hematology | Oncology
Expertise in
11
conditions
Dr. Farzana D. Pashankar
Hematology | Oncology
Referral may be required

Yale New Haven Hospital

20 York St, 
New Haven, CT 
 (33.7 miles away)
203-785-4081
Languages Spoken:
English
See accepted insurances

Farzana Pashankar is a Hematologist and an Oncologist practicing medicine in New Haven, Connecticut. Dr. Pashankar is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Germ Cell Tumor, Teratoma of the Mediastinum, Testicular Yolk Sac Tumor, Bone Marrow Aspiration, and Bone Marrow Transplant.

Expertise in
22
conditions
Dr. Harriet Kluger
Hematology | Oncology
Expertise in
22
conditions
Dr. Harriet Kluger
Hematology | Oncology
Referral may be required

Smilow Cancer Hospital

35 Park St, # Np8, 
New Haven, CT 
 (33.7 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Harriet Kluger is a Hematologist and an Oncologist practicing medicine in New Haven, Connecticut. Dr. Kluger is highly rated in 22 conditions, according to our data. Her clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Renal Cell Carcinoma (RCC), Metastatic Brain Tumor, and Nephrectomy.

Expertise in
15
conditions
Dr. Michael S. Isakoff
Hematology | Oncology | Pediatrics
Expertise in
15
conditions
Dr. Michael S. Isakoff
Hematology | Oncology | Pediatrics
Referral may be required

CCMC - Hematology

282 Washington St, 
Hartford, CT 
 (0.1 miles away)
860-545-9630
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Michael Isakoff is a Hematologist and an Oncologist practicing medicine in Hartford, Connecticut. Dr. Isakoff is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Osteosarcoma, Adult Soft Tissue Sarcoma, Ewing Sarcoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Isakoff is board certified in American Board Of Pediatrics and American Board Of Pediatrics, Pediatric Hematology & Oncology, Pediatric Hematology Oncology . Dr. Isakoff is currently accepting new patients.

Frequently Asked Questions about Dr. Jaykumar Thumar

How do I make an appointment with Dr. Jaykumar Thumar?

You can book an appointment with Dr. Jaykumar Thumar by calling their office at 860-676-7000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jaykumar Thumar a top-rated expert for ALK-Positive Non-Small Cell Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jaykumar Thumar is classified as an Advanced expert for ALK-Positive Non-Small Cell Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jaykumar Thumar specialize in?

While Dr. Jaykumar Thumar is a Hematology, they have specific expertise in ALK-Positive Non-Small Cell Lung Cancer, Essential Thrombocythemia, and Classical Hodgkin Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Jaykumar Thumar participate in research or clinical trials?

Yes. Dr. Jaykumar Thumar has published 11 articles and abstracts on conditions like ALK-Positive Non-Small Cell Lung Cancer. You can view a list of Dr. Jaykumar Thumar's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jaykumar Thumar accept my insurance?

Dr. Jaykumar Thumar accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 860-676-7000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Thumar's expertise for a condition
ConditionClose
      View All 20 Advanced Conditions
      View All 62 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile